Salvage chemotherapy with mitomycin, vindesine, and cisplatin (MiViP) in recurrent carcinoma of the cervix

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 2, 1996, Pages 204-206

  Delaloye, Jean François ^a   Leyvraz, Serge ^a   Adjahoto, Etsé Outcha ^a   Bauer, Jean ^a   De Grandi, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cervix carcinoma; Cisplatin; Mitomycin; Salvage chemotherapy; Vindesine

Indexed keywords

CISPLATIN; MITOMYCIN; VINDESINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CARCINOMA; CISPLATIN; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; MITOMYCINS; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VINDESINE;

EID: 0029923102     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199604000-00024     Document Type: Article

References (15)

1. Levi JA, Wheeler HR, Friedlander M, Tattersall MHN, Kefford R, Dalley D. Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix. Gynecol Oncol 1992;45:329-33.
2. Muscato MS, Perry MC, Yarbro JW. Chemotherapy of cervical carcinoma. Semin Oncol 1982;9:373-87.
3. Rhomberg WU. Vindesine for recurrent and metastatic cancer of the uterine cervix: a phase II study. Cancer Treat Rep 1986;70: 1455-7.
4. Hoffman MS, Kavanagh JJ, Roberts WS, et al. A phase II evaluation of cisplatin, bleomycin and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 1991;40:144-6.
5. Blackledge G, Buxton EJ, Mould JY, et al. Phase II studies of ifosfamide alone and in combination in cancer of the cervix. Cancer Chemother Pharmacol 1990;26(suppl):12-6.
6. Ramm K, Vergote IB, Kaern J, Tropé CG. Bleomycin-ifosfamide-cisplatinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Gynecol Oncol 1992;46: 203-7.
7. Hoffman MS, Roberts WS, Bryson SCP, et al. Treatment of recurrent and metastatic cervical carcinoma with cisplatin. doxorubicin, and cyclophosphamide. Gynecol Oncol 1988;29: 32-6.
8. Rotmensch J, Senekjian EK, Javaheri G, Herbst AL. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol 1988;29:76-81.
9. Bonomi P, Blessing J, Ball H, Hanjani P, DiSaia PJ. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol 1989;34:357-9.
10. Kaern J, Tropé C, Kjørstad K, et al. A phase II study of 5-fiuorouracil/cisplatin in recurrent cervical cancer. Tijdschr Nor Laegeforen 1990;110:2759-62.
11. Macia M, Novo A, Ces J, et al. Neoadjuvant and salvage chemotherapy with cisplatin (CDDP) and 5-fluorouracil (5-FU) in cervical carcinoma. Eur J Gynaecol Oncol 1993;14:192-6.
12. Joss R, Castiglione M, Goldhirsch A, Ryssel H, Tschopp L, Brunner K. Mitomycin, vindesine, and cisplatin in the treatment of non-small cell lung cancer: a pilot study of the Swiss Group for Clinical Cancer Research (SAKK). Cancer Chemother Pharmacol 1985;14(suppl):36.
13. World Health Organization. WHO Handbook for reporting results of cancer treatment. Geneva: World Health Organization, 1979.
14. Joss RA, Bürki K, Dalquen P, et al. Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center. Cancer 1990;65:2426-34.
15. Potter ME, Hatch KD, Potter MY, Shingleton HM, Baker VV. Factors affecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 1989;63:1283-6.